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Melanocytic naevi, dysplastic naevi, horizontally growing mela-
noma (radial growth phase), invasively growing melanoma
(vertical growth phase), and metastasizing melanoma are thought
to represent successive stages in the tumour progression of the
melanocytic lineage. Melanocytic transformation is accompanied
by specific changes in gene expression. Some 200–300 genes 
are supposed to be differentially expressed between normal and
cancer cells (Zhang et al, 1997) contributing to the malignant
phenotype of tumours. Several genes have already been identified
to be differentially expressed in malignant melanoma. Specific
examples include the melanoma-associated antigens MAGE and
PRAME (van der Bruggen et al, 1991; Ikeda et al, 1997), the
tumour suppressor p16/CDKN2 (Reed et al, 1995), the melanocyte
lineage marker Pmel17/gp100 (Wagner et al, 1997), and the
epidermal growth factor (EGF) receptor (Real et al, 1986).
Nevertheless, further data is needed to provide better insight in the
tumour biology of melanoma because individually none of these
genes has been shown to be aetiologically involved in tumour
progression (Herlyn, 1993). It is also well accepted that multiple
and independent events lead to an accumulation of genetic defects
that determine the malignant phenotype of tumours.
Gene expression patterns in vitro also differ from those in vivo
because of the cell culture conditions and the altered microenvi-
ronment of the cells. Results obtained from tumour tissues may
therefore be more reliable than those from cell lines. However,
when dealing with tissues there are significant problems such as
the limited number of primary tumour samples available, the
heterogeneity of the tissues, individual tissue variations, and the
difficulty in isolating high-quality RNA in sufficient amounts from
biopsies that are hard to homogenize (e.g. skin). We therefore used
the following strategies to overcome these problems: (i) A modi-
fied RNA isolation step was established to obtain high-quality
RNA from skin biopsies (Hipfel et al, 1998); (ii) for difference
analysis five primary melanoma and five melanocytic naevi were
pooled, respectively, to reduce the number of genes obtained due
to individual tissue variations; (iii) a polymerase chain reaction
(PCR)-based subtractive hybridization method was applied that
allows the enrichment of low abundant differential transcripts and
requires less RNA than conventional subtractive hybridization
techniques; (iv) arrayed filters were used for high-throughput gene
expression difference analysis (reverse Northern blot); and (v)
finally Northern blot analysis using selected gene fragments as
probes were used to confirm differential gene expression in a
range of relevant tissues and cell lines. This procedure led to the
identification of several genes, including some unknown genes
and expressed sequence tags, that have never previously been
associated with melanocytic transformation.
MATERIALS AND METHODS
Tissue specimen collection and RNA extraction
A total of 100–250 mg of five benign congenital melanocytic
naevi (measuring less than 10 cm in diameter) and five primary
melanoma tissues (tumour thickness ranged between 1.04 mm and
3.3 mm) were snap-frozen in liquid nitrogen immediately after
resection. Benign congenital instead of acquired melanocytic
naevi were used to get sufficient RNA for the subtraction. None of
these congenital melanocytic naevi demonstrated any signs of
architectural disorder or cytologic atypia in the naevocytes. Tissue
samples were also collected from skin (safety margin of melanoma
surgical specimen) and melanoma metastases of the skin and
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modified procedure based on a guanidinium thiocyanate
(GTC)–phenol mixture (RNA-Clean™; AGS, Heidelberg,
Germany) as described previously (Hipfel et al, 1998). Integrity of
the RNA was checked by gel electrophoresis revealing two bright
bands corresponding to ribosomal 28S and 18S RNA at about 4.5
and 1.9 kb, respectively, with a ratio not smaller than 1:1. Poly-
adenosine (Poly-A) RNA was isolated from the total RNA prepa-
ration using the Quickprep Micro mRNA Purification Kit
(Pharmacia Biotech, Freiburg, Germany) with yields between 1
and 5%.
PCR-based subtractive hybridization
Reciprocal subtractive hybridizations were carried out between
cDNAs from melanoma and naevi tissues using the PCR-Select™
cDNA Subtraction Kit (Clontech, Palo Alto, CA, USA) as
described in the instructions to enrich for both melanoma-specific
and naevus-specific transcripts.
Briefly, poly-A RNA from five melanoma biopsies and five
congenital melanocytic naevi from different patients were pooled
respectively. As starting material, 2 mg poly-A RNA each was
used for first-strand and second-strand cDNA synthesis. After
RsaI-digestion and adaptor ligation hybridization of tester and
driver were performed for 8 h (first hybridization) and 15 h
(second hybridization) at 68°C. Two PCR steps were performed to
amplify differentially expressed genes (first PCR: 27 cycles of
94°C 30 s, 66°C 30 s and 72°C 1.5 min; nested PCR: 12 cycles of
94°C 30 s, 66°C 30 s and 72°C 1.5 min) using the 50 ´ Advantage
KlenTaq Polymerase Mix (Clontech). Efficiencies of RsaI-
digestions, adaptor ligations and subtractive hybridizations were
checked as recommended in the kit.
Subtracted cDNAs were inserted into the EcoRV site of
pBluescript® II SK (Stratagene, Heidelberg, Germany) and trans-
formed into INVaF¢ cells (Invitrogen, Leek, The Netherlands).
Arrayed filters and hybridization analysis (reverse
Northern blot)
To isolate individual cDNAs of the subtracted library single bacte-
rial transformants were incubated in 100 ml LB amp (50 mg ml–1)
at 37°C for at least 4 h. Inserts were PCR amplified (95°C 30 s,
56°C 30 s and 72°C 2.5 min for 30 cycles) in 20 ml containing 
10 mM Tris–HCl pH 9.0, 1.5 mM magnesium chloride (MgCl2), 
50 mM potassium chloride (KCl), 200 mM dNTP, 0.5 mM vector-
specific SK and KS primers, 1.5 Units Taq polymerase (Pharmacia
Biotech), and 1 ml of bacterial culture.
Then, 1.5 ml of a mixture containing 3 ml PCR-amplified inserts
and 2 ml 0.3 N sodium hydroxide (NaOH)/15% Ficoll were spotted
onto a 10 ´ 10 cm positively charged nylon membrane
(Boehringer Mannheim, Germany). In this way, 100 spots were
arrayed on duplicate filters for subsequent hybridization. The first
differential screening step consists of hybridizations of the
subtracted library with itself to minimize background (Wang and
Brown, 1991). The probes were made of the nested PCR product
of the subtractions with melanoma as tester (melanoma subtracted
probe) or naevi as tester (naevi subtracted probe) following 
the instructions of the Clontech subtraction kit. Labelling with
Digoxigenin was performed with the DIG DNA Labelling 
Kit (Boehringer Mannheim). Hybridizations were carried out
overnight in a buffer containing 6 ´ SSC (saline–sodium citrate),
50 mg ml–1 denatured salmon sperm DNA, 5 ´ Denhardt’s solution
(0.2% (w/v) Ficoll 400, polyvinylpyrrolidone and bovine serum
albumin (BSA) each), and 0.5% sodium dodecyl sulphate (SDS) at
65°C. The filters were washed twice in 2 ´ SSC/0.5% SDS at 65°C
for 10 min and twice in 1 ´ SSC/0.5% SDS at 65°C for 10 min,
and subjected to detection using anti-DIG–AP conjugates 
and CDP-Star™ as chemiluminescent substrate according to 
the instructions of the DIG DNA Detection Kit (Boehringer
Mannheim). Blots were exposed to Kodak X-OMAT chemilumi-
nescent film at room temperature for several minutes.
Clones confirmed to be differentially expressed in this first
screening step were again arrayed on duplicate filters as described
above and subjected to the second differential screening step with
hybridizing probes made of unsubtracted cDNA from melanoma
tissues (melanoma cDNA probe) and unsubtracted cDNA from
naevus tissues (naevi cDNA probe). RNA used for the synthesis of
these probes were from the same pool of RNA used for sub-
traction. Probes were labelled with Digoxigenin during cDNA-
synthesis in 40 ml containing 1 mg mRNA, 50 mM Tris–HCl 
pH 8.3, 75 mM KCl, 3 mM MgCl2, 2.5 mM dithiothreitol (DTT), 4
ml 10 ´ DIG dNTP labelling mixture (Boehringer Mannheim), 
1 mM T20-primer, and 100 Units SuperScript™ II RNAase 
H2 reverse transcriptase (Gibco-BRL, Eggenstein, Germany) for 1
h at 42°C. Hybridization, washing of the filters, and detection of
the signals were performed exactly as described for the first
screening step.
Sequencing and computer analysis
Cloned cDNAs that were confirmed to be differentially expressed
in the first and second differential screening step were sequenced
using the BigDye Terminator Cycle Sequencing reagents (Perkin-
Elmer, Foster City, CA, USA) and an ABI373 DNA Sequencer.
Identification of sequences was performed using the non-
redundant database of GenBank, EMBL, DDBJ and PDB (BLAST
program).
Northern analysis
To further confirm differential gene expression 1 mg mRNA from
several melanoma, melanocytic naevi, skin, melanoma metastases
and melanoma cell lines was fractionated on a 1% Northern gel and
transferred to a positively charged nylon membrane (Boehringer
Mannheim). The blot was hybridized with DIG-labelled cDNA
fragments of the confirmed clones (67-kDa laminin receptor,
dbpB/YB-1, CAGH-3, 71-kDa heat shock protein, novel gene, EST
ac73 g10.sl). Hybridization was performed overnight at 50°C in
DIG Easy Hyb (Boehringer Mannheim). The filters were washed
twice in 2 ´ SSC / 0.1% SDS at room temperature for 2 min and
twice in 2 ´ SSC / 0.1% SDS at 50°C for 15 min, and subjected to
Digoxigenin detection as described above. Hybridization signals
were quantified by scanning the chemiluminescent film and
volume integration using the Molecular Analyst™ program (Bio-
Rad Laboratories, Hercules, CA, USA).
Expression patterns of differentially expressed genes in other
human tissues were determined using the RNA Master Blot™
(Clontech) with dots of poly-A RNA from 50 different tissues 
and developmental stages. Hybridizing probes were radioactive
labelled with the Klenow fragment of DNA polymerase I (MBI
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and 1 mg hexamer primer (Feinberg and Vogelstein, 1983).
Hybridization and washing were carried out according to the
manufacturers’ instructions. Filters were exposed to an autoradi-
ography film, and hybridization signals were quantified using a
Phosphorimager (Fujifilm BAS 1500).
RESULTS
PCR-based subtractive hybridization comparison of
gene expression patterns between malignant
melanoma and melanocytic naevus tissues
Reciprocal PCR-based subtractive hybridizations were carried out
between primary melanoma and melanocytic naevi cDNAs to
identify melanoma-specific genes (melanoma as tester) and
naevus-specific genes (naevi as tester). Subtraction efficiency was
determined using a semi-quantitative PCR for gluceraldehyde 3-
phosphate dehydrogenase (GAPDH). A significant reduction of
the cDNA of the abundant housekeeping gene GAPDH was
observed in subtracted compared to unsubtracted cDNA for both
naevi as tester and melanoma as tester indicating that the subtrac-
tive hybridizations were successful (Figure 1A). Differences of
about seven cycles and 13 cycles for equal amplification of
GAPDH were seen in the subtraction with melanoma as tester and
with naevi as tester, respectively, suggesting that the latter was
more efficient (five cycles correspond roughly to a 20-fold cDNA
concentration difference).
For further verification of successful subtractive hybridizations
tyrosinase, a melanocytic lineage marker known to be over-
expressed in melanoma compared to naevi (Herlyn, 1993) was
amplified. As seen in Figure 1B, an enrichment of tyrosinase tran-
scripts was seen in the subtraction with melanoma as tester and a
reduction of tyrosinase transcripts with naevi as tester.
Moreover, the melanoma-associated antigen PRAME (Ikeda et
al, 1997) was present in much higher quantities in the melanoma-
specific subtracted library than in the naevus specific subtracted
library (data not shown).
Use of arrayed filters to screen large numbers of cDNA
inserts of the subtracted library
The enriched cDNAs of the subtractions were cloned, and individual
inserts were PCR amplified and spotted onto duplicate nylon
membranes (arrayed filters). Insert sizes ranged between 200 bp and
1400 bp (average size was about 400 bp). In the first differential
screening step the clones were hybridized with a probe made of the
subtracted library itself (Wang et al, 1991) to eliminate non-differen-
tial clones (Figure 2). Of 549 clones, 337 (61%) revealed differential
signals (174 melanoma-specific and 163 naevus-specific clones)
and were therefore subjected to the second differential hybridization
step with probes made of unsubtracted cDNA from melanoma
tissues and naevus tissues, respectively. A high percentage of the
clones (72%) revealed no signal at all, suggesting that among these
cDNA low abundant transcripts are present that cannot be detected
in this way. Thirty-eight clones (11%) were confirmed to be differ-
entially expressed, 22 melanoma-specific clones and 16 naevus-
specific clones (Table 1). These clones were sequenced and analysed
by database searching with the BlastN program (Altschul et al,
1997). In Figure 3 representative clones of the arrayed filters are
Differential gene expression in melanoma 1151
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Figure 1 PCR analysis of subtraction efficiency. After reciprocal subtractive
hybridizations with melanoma and naevi as tester, respectively, GAPDH (A)
and tyrosinase (B) were PCR-amplified with 18, 23, 28 and 33 cycles in (A),
and 10, 15, 20, 25 and 30 cycles in (B) indicated by triangles with subtracted
and unsubtracted cDNA. This shows that the abundant housekeeping gene
GAPDH is significantly reduced in both subtractions, and tyrosinase is
enriched in the subtraction with melanoma as tester and reduced in the
subtraction with naevi as tester
Figure 2 First differential screening step using arrayed filters hybridized
with subtracted cDNA probes. Individual clones of the subtracted libraries
were spotted onto duplicate nylon membranes (clones of the subtraction with
melanoma as tester are localized in the upper halves of the filters, clones of
the subtractions with naevi as tester in the lower halves). The arrayed filters
were hybridized with a melanoma subtracted probe (left) and a naevi
subtracted probe (right) revealing most genes to be differentially expressed
and some to be false-positive or false-negative
Table 1 Array hybridization with unsubtracted cDNA as probes
Number of clones Non-differential Clones without Differentially
clones (%) detectable signal (%) expressed clones (%)
Melanoma as tester 174 19 (11) 133 (76) 22 (13)
Naevi as tester 163 39 (24) 108 (66) 16 (10)
Total 337 58 (17) 241 (72) 38 (11)shown, and in Tables 2 and 3 all clones are listed with the insert
sizes and the GenBank matches. Among these, there were several
genes already known to be differentially expressed (e.g. S-100, gp
100), some genes that have never been associated with the malig-
nant phenotype (e.g. CAGH-3, dbpB/YB-1), and some unknown
sequences (novel genes and expressed sequence tags).
Northern analyses to examine expression of genes in a
range of tissues and cell lines
To further confirm differential gene expression between benign
and malignant melanocytic lesions, and to investigate the expres-
sion profile during melanoma progression, six genes were selected
(marked in Tables 2 and 3) to use as probes on Northern blots
using RNA from different sources: skin, common congenital
melanocytic naevi, primary melanoma, lymph node and skin
metastases of melanoma as well as various melanoma cell lines.
Quantification of the hybridization signals revealed all six genes to
be differentially expressed between benign and malignant
melanocytic lesions (Figure 4). Interestingly, expression of one
gene, the 67-kDa laminin receptor, showed a correlation with
tumour progression (Figure 4A) that is consistent with the data in
the literature (Vacca et al, 1993) but contradicts the result of the
arrayed hybridization where the gene is preferentially expressed in
naevi (Table 3).
Expression of dbpB/YB-1 correlates with tumour progression
since skin and three of three naevi showed almost no signal,
whereas all of the examined melanoma, melanoma metastases and
melanoma cell lines revealed significant stronger signals (Figures
4B and 5A).
CAGH-3 was not found in skin and in none of the eight naevi
examined, whereas a weak signal could be detected in one of five
primary melanomas. A strong signal was seen in two of four
lymph node metastases and in one of one skin metastasis. In addi-
tion, four of five melanoma cell lines were positive for CAGH-3
(Figure 4C).
The novel gene (clone 8 in Table 3) was strongly expressed in
skin and in four of five melanocytic naevi but not in primary
melanoma, lymph node metastases, skin metastasis and melanoma
cell lines (Figures 4D and 5B). The transcript is about 0.5 kb in
length and shows no homology to any known sequence (BLAST
search and search in the TIGR database).
The  EST ac73 g10.sl was not detected in skin, naevi and
primary melanoma but was expressed in one of three lymph node
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Figure 3 Second differential screening step using arrayed filters hybridized
with unsubtracted cDNA probes. The clones confirmed in the first screening
step were again spotted onto duplicate filters and hybridized with
unsubtracted cDNA from melanoma (MM) and unsubtracted cDNA from
naevi (N) respectively. Eight of the 38 clones that were confirmed in both
screening steps are shown (six melanoma-specific genes and two naevus-
specific genes)
Table 2 Gene fragments expressed preferentially in malignant melanoma (reverse Northern)
Clone Accession Identity Approximate Homology region
number insert size
1 S73003 gp100 200 1900–2011
2 U03698 HLA B-40011 300 856–560
3 M87790 Ig l anti-hepatitis A 400 588–198
4 M21731 Lipocortin V 550 778–1285
5 X58079 S-100 210 194–59
6 U80747 CAGH-3 520 2001–1694
7 M17783 Glia-derived nexin 600 120–583
8 X04106 Calpain 500 657–1100
9 S73003 gp100 350 1903–1588
10 S73003 gp100 180 1181–1021
11 L28809 dbpB/YB-1 650 925–578
12 M95708 CD59 350 325–575
13 D29011 Proteasome subunit X 220 911–1018
14 M33519 BAT3 800 3025–2648
15 S73003 gp100 550 652–852
16 AC002431 Human BAC clone RG180F08 700 106029–106280
17 T59964 EST yb67e03.r1 360 161–5
18 X15183 90-kDa heat shock protein 700 2293–2110
19 AA470116 EST zt98g04.r1 600 437–312
20 AA633960 EST ac73g10.s1 700 285–656
21 S73003 gp100 600 481–905
22 Y00371 71-kDa heat shock cognate protein 600 1032–1244
Gene fragments preferentially expressed in primary malignant melanoma identified by arrayed filter hybridizations.
Bold lettering indicates the genes that were analysed on Northern blot. The homology search was performed using
the BLAST program with sequence identities between 93% and 100%. The homology region corresponds to the
nucleotide positions within the GenBank sequence.metastases, in one of one skin metastasis, and in five of five
melanoma cell lines. This suggests that this gene is up-regulated in
malignant melanocytes (Figure 4E). The transcript is about 2.9 kb
in length and shows homology to the 3’end of murine necdin (367
of 372 bases).
Finally, the 71-kDa heat shock cognate protein is weakly
expressed in skin and in four of four melanocytic naevi and is
highly expressed in all melanoma cell lines, lymph node and skin
metastases examined.
In addition, the RNA Master Blot™ (Clontech) with RNA from
50 different tissues and developmental stages was applied to deter-
mine the overall expression profiles of the novel gene, the EST
ac73 g10.sl, CAGH-3 and dbpB/YB-1 that were confirmed to be
differentially expressed in melanoma. The Master Blot was
normalized to the mRNA expression levels of eight different
housekeeping genes: ribosomal protein S9, 23-kDa highly basic
protein, tubulin, phospholipase, HPRT, b-actin, G3PDH and ubiq-
uitin. A probe for ubiquitin was used as control showing a fairly
consistent hybridization signal from all sample dots (data not
shown). The Master Blot also contained yeast total RNA and
tRNA, Escherichia coli rRNA and DNA, as well as human Cot1
DNA as negative controls that all showed no detectable signal in
any of the hybridizations. Hybridization with EST ac73 g10.sl as a
probe revealed that the gene is mainly expressed in pituitary gland
and in placenta. The novel gene (clone 8 in Table 3) showed no
detectable signal in any of the 50 tissues analysed and seems there-
fore be expressed exclusively in melanocytic naevi and normal
skin. dbpB/YB-1 is expressed in most tissues but mainly in
skeletal muscle, testis, heart, fetal liver and fetal heart. Finally,
CAGH-3 is most prominently expressed in placenta and to a much
lower extent in ovary and brain.
DISCUSSION
The identification of genes specifically overexpressed or repressed
in tumour tissues is a key step towards the understanding of the
malignant transformation process. In this study a PCR-based
subtractive hybridization method was applied to detect genes
differentially expressed in malignant and benign melanocytic
lesions using primary melanoma and benign melanocytic naevus
tissues. We obtained two subtracted cDNA libraries of good
quality as demonstrated by a significant reduction of cDNA of the
abundant housekeeping gene GAPDH in subtracted compared to
unsubtracted cDNAs. Furthermore, the melanoma-associated
antigen PRAME (Ikeda et al, 1997) was present in much higher
quantities in the melanoma-specific library than in the naevus-
specific library.
High-quality RNA is needed for this technique but this is diffi-
cult to extract from small amounts of skin tissues. We therefore
established an optimized protocol as described previously (Hipfel
et al, 1998). Only a few studies have so far used tissues as starting
material, most studies comparing gene expression between cell
lines. Analysis of genes in tissues, however, has two major advan-
tages. First, gene expression patterns are not altered due to growth
factors and other additions to the culture media, and second, genes
can be identified that are differentially regulated in benign and
malignant lesions due to cell–cell interactions between
melanocytes, fibroblasts and keratinocytes. It is known, for
example, that the gene expression profile of melanocytes is partly
regulated by keratinocytes, e.g. the expression of the MUC18
adhesion receptor (Shih et al, 1994), and that escape from
keratinocyte control is a first step towards melanocytic transforma-
tion. In addition, melanoma cells produce a large number of
Differential gene expression in melanoma 1153
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Table 3 Gene fragments expressed preferentially in melanocytic naevi (reverse Northern)
Clone Accession Identity Approximate Homology region
number insert size
1 M99061 Epidermal cytokeratin 2 900 2040–1619
2 M10938 Epidermal 67-kDa type II keratin 150 1848–1733
3 M99061 Epidermal cytokeratin 2 600 2046–1604
4 M10938 Epidermal 67-kDa type II keratin 510 166–608
5 M61120 Loricrin 200 1167–994
6 W56586 EST zd16d06.s1 1200 411–78
7 J03464 Collagen alpha-2 type I 900 5338–4933
8 Novel 400
9 X89401 Large subunit of ribosomal protein L21 300 382–149
10 M17733 Thymosin beta-4 500 249–547
11 M54927 Myelin proteolipid protein 280 1295–1137
12 S37431 67-kDa laminin receptor 700 125–555
13 M10938 Epidermal 67-kDa type II keratin 280 1848–1917
14 AF052153 Aspartate aminotransferase 150 1517–1344
15 X06537 Lecithin-Cholesterol 400 1–158
acyltransferase
16 Novel 500
Gene fragments preferentially expressed in melanocytic naevi identified by arrayed filter hybridizations. Bold
lettering indicates the genes that were analysed on Northern blot. The homology search was performed using
the BLAST program with sequence identities between 93% and 100%. The homology region corresponds to
the nucleotide positions within the GenBank sequence. Clones that show no homology to any known sequence
(non-redundant database of GenBank, EMBL, DDBJ and PDB, as well as GenBank EST division) are denoted
as novel.1154 R Hipfel et al
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Figure 4 Quantification of Northern hybridization signals of six genes by scanning and volume integration. The cloned transcript fragments of the 67-kDa
laminin receptor (A), the dbpB/YB-1 (B), the CAGH-3 (C), the novel gene (D), the EST ac73 g10.s1 (E) and the 71-kDa heat shock protein (F) were used as
probes on Northern blots. All genes were confirmed to be preferentially expressed in either malignant lesions (A–C, E–F) or in normal skin and benign lesions
(D). Depths of invasion of the primary melanoma (Clark level I–V) are indicated (Clark et al, 1969). 28S rRNA was used as control. Approximate sizes of the
transcripts were 1 kb (A), 1.6 kb (B), 2.3 kb (C), 0.5 kb (D), 2.9 kb (E) and 2.3 kb (F). Relative units (x-fold): Integrated volume of the bands on the Northern blot
adjusted for background removal using the Molecular Analyst® Software (Bio-Rad)soluble factors affecting the expression profile of the neighbouring
cells which may also be of importance for the progression of the
tumour (Herlyn and Shih, 1994). We therefore did not apply
microdissection techniques to obtain all cell types of the skin for
the subtraction analysis.
We demonstrated that PCR-based subtractive hybridization with
RNA isolated from skin tissues is a powerful technique to identify
a large number of differentially expressed genes. The method
prevents amplification of common sequences and allows the
enrichment of rare messages by means of the suppression PCR
(Siebert et al, 1995; Diatchenko et al, 1996). The application of
two consecutive differential screening procedures allowed a step-
to-step elimination of non-differential clones. The first screening
consisting of self-hybridizations of the subtracted library (Wang
and Brown, 1991) led to the elimination of 212 of 549 analysed
clones (39%) and is therefore a valuable tool to reduce the number
of non-differential clones. The second screening consisting of
hybridizations with unsubtracted cDNA as probes led to the elimi-
nation of another 58 non-differential clones (17%). The majority
of clones, however, represented transcripts without detectable
signals on the arrayed filters (Table 1). This is probably due to the
low-abundance of these transcripts as they were detected with the
amplified subtracted cDNA probe in the first screening step but
not detected with the non-amplified unsubtracted cDNA probe in
the second screening step. This high number of rare transcripts
reflects the strength of the suppression PCR and it would be inter-
esting to analyse with a different screening procedure how many
of these rare transcripts are differentially expressed.
Sequencing of the 38 confirmed cDNA clones showed that a
high number of different genes (30 of 38) were detected, reflecting
the high quality of the subtracted library (Tables 2 and 3). Only
gp100 and keratin was detected several times (five clones each).
gp100 is a melanocytic lineage marker that is known to be signifi-
cantly overexpressed in melanoma (Wagner et al, 1997). This
result shows the high efficiency and reliability of the subtraction
technique. S100, a calcium-binding protein that is diagnostic of a
lesion of melanocytic origin, was found once in the melanoma-
specific library and might as well be overexpressed in melanoma
cells. In the naevus-specific library, two of the 16 identified genes
are known to be expressed mainly in keratinocytes and were
isolated several times (keratin and loricrin). The fact that many
keratinocyte-specific genes are found in the naevus-specific
library suggests that keratinocyte RNA is overrepresented in
naevus tissues compared to melanoma biopsies. In the tumour
tissues most likely the transcription of many different genes are
switched on to facilitate the uncontrolled growth of the tumour
cells. This can result in the underrepresentation of keratinocyte-
specific genes in the melanoma-specific library.
Of the 38 differentially expressed clones, seven genes were
unknown, four melanoma-specific and three naevus-specific tran-
scripts (Tables 2 and 3) including a sequence contained in a human
BAC clone (RG180F08), four expressed sequence tags (ESTs),
one unknown gene (clone 16 in Table 3) that shows a small
homology to bovine desmoglein (81/92 bases), and one sequence
that shows no homology to any known gene (clone 8 in Table 3).
The latter revealed a very restrictive expression pattern, and it has
yet to be clarified in which skin cell the gene is expressed.
Although tissues from different patients were compared only two
polymorphic genes were detected (HLA B and Ig l).
Six of the identified genes were selected to further confirm
differential gene expression on Northern blot including CAGH-3,
dbpB/YB-1, EST ac73 g10.sl, 71-kDa heat shock cognate protein,
the novel gene (clone 8 in Table 3), and 67-kDa laminin receptor.
All six genes were confirmed to be differentially expressed
between benign and malignant melanocytic lesions. The results of
the array hybridizations were confirmed in five cases, reflecting
the strength and usefulness of the technique. However, the sixth
gene, the 67-kDa laminin receptor was found on Northern blot to
be higher expressed in melanoma which is in line with published
data (Vacca et al, 1993) but contradicts the finding of the array
hybridization. This demonstrates that array hybridization is a good
tool for screening large numbers of clones but Northern blot is
necessary to confirm the results for the individual clones.
CAGH-3 was initially found by screening human brain cDNA
libraries with (CAG)n probes to identify new candidate genes for
neuropsychiatric diseases arising from trinucleotide repeat expan-
sion mutations (Neri et al, 1996). Gene products with several glut-
amine residues may function as transcription factors and have a
potential role in neurodevelopment (Margolis et al, 1997). The fact
that CAGH-3 is also expressed in primary melanoma, melanoma
metastases and melanoma cell lines (Figure 4C) could be
explained by the origin of the melanocytes from the neural crest.
CAGH-3 may be a transcription factor that is involved in the
melanocytic transformation process. In addition, we found that
Differential gene expression in melanoma 1155
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Figure 5 Northern blot hybridizations. The cloned fragments of the
dbpB/YB-1 (A), the novel gene (B), and the 71-kDa heat shock protein (C)
were used as probes on Northern blots. The dbpB/YB-1 (1.6 kb) was
confirmed to be overexpressed in melanoma, melanoma metastases, and
melanoma cell lines, whereas the novel gene (0.5 kb) was confirmed to be
preferentially expressed in benign lesions (naevi) and skin. The 71-kDa heat
shock protein (2.3 kb) was preferentially expressed in malign melanocytic
lesions. Although the product is almost not expressed in benign melanocytes
in vivo (naevi), it is strongly expressed in melanocytes in vitro. Depths of
invasion of the primary melanoma (Clark level I–V) are indicated (Clark et al,
1969)CAGH-3 is expressed in high quantities in placenta, much higher
than in brain and ovary, suggesting that CAGH-3 also plays a role
outside the brain.
The 71-kDa heat shock protein shows an increase in gene
expression with tumour progression. This gene is also expressed in
normal melanocytes in vitro suggesting that there are substantial
differences in the expression profile between benign melanocytic
lesions and melanocytes in vitro (Figures 4F and 5C). This protein
is supposed to have important roles as multifunctional chaperone
including modulation of oncogene-mediated transformation, e.g.
interaction with p53 (Yehiely and Oren, 1992).
dbpB/YB-1 is a member of a DNA-binding protein family,
contains a cold shock domain and is regarded as transcriptional
regulator (Kudo et al, 1995). Binding of dbpB/YB-1 to the
epidermal growth factor receptor (EGFR) enhancer (Sakura et al,
1988) may lead to an up-regulation of EGFR. Interestingly,
expression of EGFR correlates with melanoma progression
(Rodeck, 1993). To our knowledge, expression of dbpB/YB-1 has
never been associated until now with melanocytic transformation.
In 27 out of 27 primary breast tumours dbpB/YB-1 was expressed
but the gene product was undetectable in normal breast tissues
(Bargou et al, 1997). The same group found that dbpB/YB-1 can
induce MDR-1 gene expression and multidrug resistance in human
breast cancer. We found dbpB/YB-1 in many tissues, mainly in
skeletal muscle, testis and heart, confirming previous results (Kudo
et al, 1995). In addition, dbpB/YB-1 is known to be a major, cell
type-specific transactivator of matrix metalloproteinase-2 (MMP-
2) transcription by mesangial cells (Mertens et al, 1997).
It is not known whether the genes identified here can be
causally linked to melanocytic transformation but due to their
known functions in other cells they are potential candidates for
pathogenetic factors of melanoma. It remains to be demonstrated
which of the identified genes are differentially expressed in
melanocytes and which in the neighbouring other cell types, like
keratinocytes or fibroblasts. The latter are also important for
tumour progression (Herlyn and Shih, 1994) because growth stim-
ulation of normal and malignant cells, cell motility, angiogenesis,
stroma formation within malignant lesions and detachment of
tumour cells from lesions involve complex interactions between
autocrine, paracrine and endocrine factors (Herlyn and
Malkowicz, 1991).
In conclusion, we have demonstrated that PCR-based subtrac-
tive hybridization in combination with high-throughput array
hybridizations and conventional Northern blot is highly efficient
to detect differentially expressed genes even in tissues from which
high-quality RNA is difficult to isolate in sufficient amounts.
Therefore, the approach should also be useful for other tumours to
identify potential factors and novel genes involved in malignant
transformation. The transcripts identified in this study represent
valuable candidate genes for further functional analysis in malig-
nant melanoma and should be informative in studying the biology
of the tumour.
ACKNOWLEDGEMENTS
The authors thank T Iftner and colleagues for DNA sequencing
and M Schwarz and colleagues for the use of radioisotopes and
Phosphorimager. The study was supported by a grant of the
fortune programme of the Eberhard-Karls-University in
Tuebingen.
REFERENCES
Altschul SF, Madden TL, Schaffer AA, Zhang J, Zhang Z, Miller W and Lipman DJ
(1997) Gapped BLAST and PSI-BLAST: a new generation of protein database
search programs. Nucleic Acids Res 25: 3389–3402
Bargou RC, Jurchott K, Wagener C, Bergmann S, Metzner S, Bommert K, Mapara MY,
Winzer KJ, Dietel M, Dorken B and Royer HD (1997) Nuclear localization and
increased levels of transcription factor YB-1 in primary human breast cancers are
associated with intrinsic MDR1 gene expression. Nat Med 3: 447–450
Clark WH Jr, From L, Bernardino EA and Mihm MC (1969) The histogenesis and
biologic behavior of primary human malignant melanomas of the skin. Cancer
Res 29: 705–727
Diatchenko L, Lau YF, Campbell AP, Chenchik A, Moqadam F, Huang B, Lukyanov
S, Lukyanov K, Gurskaya N, Sverdlov ED and Siebert PD (1996) Suppression
subtractive hybridisation: a method for generating differentially regulated or
tissue-specific cDNA probes and libraries. Proc Natl Acad Sci USA 93:
6025–6030
Feinberg AP and Vogelstein B (1983) A technique for radiolabeling DNA restriction
endonuclease fragments to high specific activity. Anal Biochem 132: 6–13
Herlyn M (1993) Molecular and Cellular Biology of Melanoma. CRC Press: Boca
Raton, FL
Herlyn M and Malkowicz SB (1991) Regulatory pathways in tumor growth and
invasion. Lab Invest 65: 262–271
Herlyn M and Shih IM (1994) Interactions of melanocytes and melanoma cells with
the microenvironment. Pigment Cell Res 7: 81–88
Hipfel R, Garbe C and Schittek B (1998) RNA isolation from human skin tissues for
colorimetric differential display. J Biochem Bioph Meth 18: 131–135
Ikeda H, Lethe B, Lehmann F, van Baren N, Baurain JF, De Smet C, Chambost H,
Vitale M, Moretta A, Boon T and Coulie PG (1997) Characterization of an
antigen that is recognized on a melanoma showing partial HLA loss by CTL
expressing an NK inhibitory receptor. Immunity 6: 199–208
Kudo S, Mattei MG and Fukuda M (1995) Characterization of the gene for dbpA, a
family member of the nucleic-acid-binding proteins containing a cold-shock
domain. Eur J Biochem 231: 72–82
Margolis RL, Abraham MR, Gatchell SB, Li SH, Kidwai AS, Breschel TS, Stine
OC, Callahan C, McInnis MG and Ross CA (1997) cDNAs with long CAG
trinucleotide repeats from human brain. Hum Genet 100: 114–122
Mertens PR, Harendza S, Pollock AS and Lovett DH (1997) Glomerular mesangial
cell-specific transactivation of matrix metalloproteinase 2 transcription is
mediated by YB-1. J Biol Chem 272: 22905–22912
Neri C, Albanese V, Lebre AS, Holbert S, Saada C, Bougueleret L, Meier Ewert S,
Le Gall I, Millasseau P, Bui H, Giudicelli C, Massart C, Guillou S, Gervy P,
Poullier E, Rigault P, Weissenbach J, Lennon G, Chumakov I, Dausset J,
Lehrach H, Cohen D and Cann HM (1996) Survey of CAG/CTG repeats in
human cDNAs representing new genes: candidates for inherited neurological
disorders. Hum Mol Genet 5: 1001–1009
Real FX, Rettig WJ, Chesa PG, Melamed MR, Old LJ and Mendelsohn J (1986)
Expression of epidermal growth factor receptor in human cultured cells and
tissues: relationship to cell lineage and stage of differentiation. Cancer Res 46:
4726–4731
Reed JA, Loganzo F, Jr., Shea CR, Walker GJ, Flores JF, Glendening JM, Bogdany
JK, Shiel MJ, Haluska FG, Fountain JW and Albino AP (1995) Loss of
expression of the p16/cyclin-dependent kinase inhibitor 2 tumor suppressor
gene in melanocytic lesions correlates with invasive stage of tumor
progression. Cancer Res 55: 2713–2718
Rodeck U (1993) Growth factor independence and growth regulatory pathways in
human melanoma development. Cancer Metastasis Rev 12: 219–226
Sakura H, Maekawa T, Imamoto F, Yasuda K and Ishii S (1988) Two human genes
isolated by a novel method encode DNA-binding proteins containing a
common region of homology. Gene 73: 499–507
Shih IM, Elder DE, Hsu MY and Herlyn M (1994) Regulation of Mel-CAM/MUC18
expression on melanocytes of different stages of tumor progression by normal
keratinocytes. Am J Pathol 145: 837–845
Siebert PD, Chenchik A, Kellogg DE, Lukyanov KA and Lukyanov SA (1995) An
improved PCR method for walking in uncloned genomic DNA. Nucleic Acids
Res 23: 1087–1088
Vacca A, Ribatti D, Roncali L, Lospalluti M, Serio G, Carrel S and Dammacco F
(1993) Melanocyte tumor progression is associated with changes in angiogenesis
and expression of the 67-kilodalton laminin receptor. Cancer 72: 455–461
van der Bruggen P, Traversari C, Chomez P, Lurquin C, De Plaen E, van den
Eynde B, Knuth A and Boon T (1991) A gene encoding an antigen
recognized by cytolytic T lymphocytes on a human melanoma. Science 254:
1643–1647
1156 R Hipfel et al
British Journal of Cancer (2000) 82(6), 1149–1157 © 2000 Cancer Research CampaignWagner SN, Wagner C, Schultewolter T and Goos M (1997) Analysis of
Pmel17/gp100 expression in primary human tissue specimens: implications for
melanoma immuno- and gene-therapy. Cancer Immunol Immunother 44:
239–247
Wang Z and Brown DD (1991) A gene expression screen. Proc Natl Acad Sci USA
88: 11505–11509
Yehiely F and Oren M (1992) The gene for the rat heat-shock cognate, hsc70, can
suppress oncogene-mediated transformation. Cell Growth Differ 3:
803–809
Zhang L, Zhou W, Velculescu VE, Kern SE, Hruban RH, Hamilton SR, Vogelstein B
and Kinzler KW (1997) Gene expression profiles in normal and cancer cells.
Science 276: 1268–1272
Differential gene expression in melanoma 1157
British Journal of Cancer (2000) 82(6), 1149–1157 © 2000 Cancer Research Campaign